An oncologist and clinical pharmacologist with over 25 years’ experience in drug development and safety of oncology, neurology, and metabolic disease products, Peg developed TAP Pharma's safety review process, led the protocol review team, and has led or supported safety portions of many NDAs and sNDAs. For the past 12 years she has led MedAssessment, a small PVG CRO focused on safety in early development. Peg received her MD & PhD (biochemistry) from U Chicago and boards in Oncology and Clinical Pharmacology.

Mick Foy has been with the MHRA for more than 35 years, he is a member of the MHRA’s Executive Committee and has recently been appointed Director of Delivery . Amongst his responsibilities is to drive initiatives to introduce new and improved services to stakeholders. Mick is SRO for the SafetyConnect and RegulatoryConnect programmes. He also leads MHRA efforts to build PV capabilities in other countries particularly low and middle income countries as part of a global initiative with the Bill and Melinda Gates Foundation.

Eric Gascho is the Assistant VP of Government Affairs at the National Health Council, the only organization that brings together all segments of the health care community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers. In his role with the NHC, Eric helps develop policies that benefit people with chronic conditions and advocates for these policies on Capitol Hill and within the administration.